NO20053612D0 - 1,2,4-triaminobenzenderivater nyttige for behandling av forstyrrelser i sentralnervesystemet - Google Patents

1,2,4-triaminobenzenderivater nyttige for behandling av forstyrrelser i sentralnervesystemet

Info

Publication number: NO20053612D0
Authority: NO; Norway
Prior art keywords: treatment; nervous system; central nervous; system disorders; derivatives useful
Prior art date: 2002-12-27

Application number

NO20053612A

Other languages

English (en)

Other versions

NO20053612L (no

Inventor

Mario Rottlander

Morten Bang Norgaard

Christian Wenzel Tornoe

Andreas Ritzen

Nikolay Khanzhin

Original Assignee

Lundbeck & Co As H

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-12-27

Filing date

2005-07-25

Publication date

2005-07-25

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35295526&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20053612(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-12-18 Priority claimed from PCT/DK2003/000906 external-priority patent/WO2004058739A1/en

2005-07-25 Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H

2005-07-25 Publication of NO20053612D0 publication Critical patent/NO20053612D0/no

2005-09-23 Publication of NO20053612L publication Critical patent/NO20053612L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/28—Halogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/32—Oxygen atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO20053612A 2002-12-27 2005-07-25 1,2,4-triaminobenzenderivater nyttige for behandling av forstyrrelser i sentralnervesystemet NO20053612L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DKPA200202012		2002-12-27
PCT/DK2003/000906 WO2004058739A1 (en)	2002-12-27	2003-12-18	1,2,4-triaminobenzene derivatives useful for treating disorders of the central nervous system

Publications (2)

Publication Number	Publication Date
NO20053612D0 true NO20053612D0 (no)	2005-07-25
NO20053612L NO20053612L (no)	2005-09-23

Family

ID=35295526

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20053612A NO20053612L (no)	2002-12-27	2005-07-25	1,2,4-triaminobenzenderivater nyttige for behandling av forstyrrelser i sentralnervesystemet

Country Status (17)

Country	Link
KR (1)	KR20050089862A (no)
CN (1)	CN100448867C (no)
AR (1)	AR042656A1 (no)
BR (1)	BR0317748A (no)
CL (1)	CL2003002748A1 (no)
EA (1)	EA008589B1 (no)
HK (1)	HK1088317A1 (no)
IS (1)	IS2649B (no)
MY (1)	MY139844A (no)
NO (1)	NO20053612L (no)
PE (1)	PE20041015A1 (no)
PL (1)	PL377221A1 (no)
SI (1)	SI1578740T1 (no)
TW (1)	TWI325414B (no)
UA (1)	UA79666C2 (no)
UY (1)	UY28151A1 (no)
ZA (1)	ZA200504565B (no)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4200259A1 (de) *	1992-01-08	1993-07-15	Asta Medica Ag	Neue 1,2,4-triaminobenzol-derivate und verfahren zu deren herstellung
DE19539861A1 (de) *	1995-10-26	1997-04-30	Asta Medica Ag	Verwendung von 4-Amino-4-(4-fluorbenzylamino)-1-ethoxy-carbonylaminobenzen zur Prophylaxe und Behandlung der Folgen der akuten und chronischen zerebralen Minderdurchblutung sowie neurodegenerativer Erkrankungen
GB9915414D0 (en) *	1999-07-01	1999-09-01	Glaxo Group Ltd	Medical use
US6117900A (en) *	1999-09-27	2000-09-12	Asta Medica Aktiengesellschaft	Use of retigabine for the treatment of neuropathic pain
US6589986B2 (en) *	2000-12-20	2003-07-08	Wyeth	Methods of treating anxiety disorders

2003
- 2003-12-18 KR KR1020057012183A patent/KR20050089862A/ko not_active Application Discontinuation
- 2003-12-18 PL PL377221A patent/PL377221A1/pl unknown
- 2003-12-18 UA UAA200507206A patent/UA79666C2/uk unknown
- 2003-12-18 TW TW092135930A patent/TWI325414B/zh not_active IP Right Cessation
- 2003-12-18 SI SI200330827T patent/SI1578740T1/sl unknown
- 2003-12-18 CN CNB2003801076953A patent/CN100448867C/zh not_active Expired - Fee Related
- 2003-12-18 EA EA200501053A patent/EA008589B1/ru not_active IP Right Cessation
- 2003-12-18 BR BR0317748-3A patent/BR0317748A/pt not_active IP Right Cessation
- 2003-12-22 AR ARP030104782A patent/AR042656A1/es unknown
- 2003-12-24 UY UY28151A patent/UY28151A1/es not_active Application Discontinuation
- 2003-12-24 CL CL200302748A patent/CL2003002748A1/es unknown
- 2003-12-26 MY MYPI20035008A patent/MY139844A/en unknown
2004
- 2004-01-05 PE PE2004000037A patent/PE20041015A1/es not_active Application Discontinuation
2005
- 2005-05-23 IS IS7856A patent/IS2649B/is unknown
- 2005-06-03 ZA ZA200504565A patent/ZA200504565B/xx unknown
- 2005-07-25 NO NO20053612A patent/NO20053612L/no not_active Application Discontinuation
2006
- 2006-08-04 HK HK06108672.2A patent/HK1088317A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
AR042656A1 (es)	2005-06-29
IS7856A (is)	2005-05-23
EA200501053A1 (ru)	2005-12-29
IS2649B (is)	2010-08-15
PE20041015A1 (es)	2005-01-08
BR0317748A (pt)	2005-11-22
SI1578740T1 (sl)	2007-08-31
KR20050089862A (ko)	2005-09-08
CN1732162A (zh)	2006-02-08
CL2003002748A1 (es)	2005-04-08
TW200413280A (en)	2004-08-01
MY139844A (en)	2009-11-30
CN100448867C (zh)	2009-01-07
TWI325414B (en)	2010-06-01
ZA200504565B (en)	2006-08-30
HK1088317A1 (en)	2006-11-03
UA79666C2 (en)	2007-07-10
NO20053612L (no)	2005-09-23
PL377221A1 (pl)	2006-01-23
EA008589B1 (ru)	2007-06-29
UY28151A1 (es)	2004-07-30

Similar Documents

Publication	Publication Date	Title
NO20053384D0 (no)	2005-07-12	Benzazepinderivater for behandling av neurologiske forstyrrelser.
NO20043237L (no)	2004-08-02	Dihydrobenzodiazepin-2-onderivater for behandling av neurologiske forstyrrelser
AU2003249983A1 (en)	2004-02-09	Piperidines useful for the treatment of central nervous system disorders
NO20026263L (no)	2002-12-27	Sulfonyl-pyrrolidin-derivater anvendelige for behandling av neurologiske forstyrrelser
EE200100441A (et)	2002-12-16	Monoamiinide taasomastamise inhibiitorid kesknärvisüsteemi haiguste raviks
IL176581A0 (en)	2006-10-31	Immunomodulatory compounds for the treatment of central nervous system disorders
NO20041386L (no)	2004-05-11	Kombinasjoner for bahandling av immunoinflammatoriske forstyrrelser
DK1578740T3 (da)	2007-07-30	1,2,4-triaminobenzenderivater, der er egnede til behandling af lidelser i centralnervesystemet
NO20052894D0 (no)	2005-06-14	4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte
NO20043085L (no)	2004-07-13	Fremgangsmater og sammensetninger for behandling av forstyrrelser i sentralnervesystemet
DK1339406T3 (da)	2004-09-27	Piperazinderivater, fremgangsmåde til fremstilling deraf og anvendelse deraf til behandling af lidelser i centralnervesystemet
NO20055098D0 (no)	2005-11-01	Anvendelse av 10-hydroksy-10,11-dihydrokarbamazepinderivater for behandling av affektive forstyrrelser
HK1080859A1 (en)	2006-05-04	Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders
ATE292107T1 (de)	2005-04-15	Verwendung von carbonylaminoderivaten gegen zentralnervensystem-störungen
ATE256126T1 (de)	2003-12-15	5-heteroatom-alkyl substituierte 3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid derivate zur behandlung zentral nervöser system störungen
DK1309322T3 (da)	2006-10-23	Anvendelse af 3-benzoylphenyleddikesyrederivater til behandling af retinale lidelser
NO20011892L (no)	2001-06-12	3-tetrahydropyridin-4-yl-indoler for behandling av psykotiske forstyrrelser
NO20026005L (no)	2002-12-13	Indolderivater nyttige for behandlingen av CNS-forstyrrelser
IS2172B (is)	2006-11-15	Indól afleiður sem eru nytsamlegar fyrir meðhöndlun á taugakerfistruflunum
NO20012612D0 (no)	2001-05-28	Isonipecotamider for behandling av integren-formidlede lidelser
NO20053612D0 (no)	2005-07-25	1,2,4-triaminobenzenderivater nyttige for behandling av forstyrrelser i sentralnervesystemet
NO20026029L (no)	2002-12-16	Indolderivater nyttige for behandlingen av CNS-forstyrrelser
NO20012538D0 (no)	2001-05-23	Anvendelse av N-substituerte azabicycloalkanderivater for behandling av forstyrrelser i sentralnervesystemet
NO20026028L (no)	2002-12-16	Indolderivater nyttige for behandlingen av CNS-forstyrrelser
SI1534391T1 (sl)	2007-06-30	Novi piperazinil-pirazinonski derivati za zdravljenje motenj, povezanih z receptorjem 5-HT2A

Legal Events

Date	Code	Title	Description
2008-07-14	CREP	Change of representative	Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104
2011-07-25	FC2A	Withdrawal, rejection or dismissal of laid open patent application